Clinical Trial Update: Effect of Perampanel on Peritumoral Hyperexcitability in HGG [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating perampanel for reducing peritumoral hyperexcitability in patients with high-grade glioma; the trial completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Glioma, Malignant, Surgery | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-05